Evidence mapPaperPMID 36119028Full record

SynthesisFrontiers in immunology2022

Immune-inflammatory and hypothalamic-pituitary-adrenal axis biomarkers are altered in patients with non-specific low back pain: A systematic review.

Juan P Sanabria-Mazo, Ariadna Colomer-Carbonell, Meritxell Carmona-Cervelló, Albert Feliu-Soler, Xavier Borràs, Mar Grasa, Montserrat Esteve, Michael Maes, Sílvia Edo, Antoni Sanz and 1 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Juan P Sanabria-MazoInstitut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
Ariadna Colomer-CarbonellInstitut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
Meritxell Carmona-CervellóFaculty of Psychology, Autonomous University of Barcelona, Cerdanyola del Vallès, Spain.
Albert Feliu-SolerFaculty of Psychology, Autonomous University of Barcelona, Cerdanyola del Vallès, Spain.
Xavier BorràsFaculty of Psychology, Autonomous University of Barcelona, Cerdanyola del Vallès, Spain.
Mar GrasaFaculty of Biology, University of Barcelona, Barcelona, Spain.
Montserrat EsteveFaculty of Biology, University of Barcelona, Barcelona, Spain.
Michael MaesDepartment of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Sílvia EdoFaculty of Psychology, Autonomous University of Barcelona, Cerdanyola del Vallès, Spain.
Antoni SanzFaculty of Psychology, Autonomous University of Barcelona, Cerdanyola del Vallès, Spain.
Juan V LucianoInstitut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.
Universitat Autònoma de Barcelona · ESSant Joan de Déu Research Foundation · ESChulalongkorn University · THInstituto de Salud Carlos III · ESSpanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This systematic review aimed to investigate immune-inflammatory and hypothalamic-pituitary-adrenal (HPA) axis biomarkers in individuals with non-specific low back pain (NSLBP) compared to healthy control. The search was performed in five databases until 4 November 2021. Two reviewers independently conducted screenings, data extraction, risk of bias, and methodological quality assessment of 14 unique studies. All studies reported the source of the fluid analyzed: nine studies used serum, two used plasma, one used serum and plasma, and two studies used salivary cortisol. We found preliminary and limited evidence (only one study for each biomarker) of increased levels in growth differentiation factor 15 (GDF-15), interleukin-23 (IL-23), transforming growth factor-beta (TGF-β), and soluble tumor necrosis factor receptor 1 (sTNF-R1) in NSLBP. Inconsistent and limited evidence was identified for interleukin-10 (IL-10). Although C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) levels appear to increase in NSLBP, only one study per each biomarker reported statistically significant differences. Interleukin-1 beta (IL-1β), interleukin-17 (IL-17), interferon gamma (IFN-γ), and high-sensitivity CRP (hsCRP) showed no significant differences. Regarding cortisol, one study showed a significant increase and another a significant decrease. More robust evidence between GDF-15, IL-23, TGF-β, and sTNF-R1 with NSLBP is needed. Moreover, contrary to the findings reported in previous studies, when comparing results exclusively with healthy control, insufficient robust evidence for IL-6, TNF-α, and CRP was found in NSLBP. In addition, cortisol response (HPA-related biomarker) showed a dysregulated functioning in NSLBP, with incongruent evidence regarding its directionality. Therefore, our effort is to find adjusted evidence to conclude which immune-inflammatory and HPA axis biomarkers are altered in NSLBP and how much their levels are affected. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020176153, identifier CRD42020176153.

Indexed as

Low Back PainPituitary-Adrenal SystemBiomarkersC-Reactive ProteinGrowth Differentiation Factor 15HumansHydrocortisoneHypothalamo-Hypophyseal SystemInterferon-gammaInterleukin-10Interleukin-17Interleukin-1betaInterleukin-23Interleukin-6Receptors, Tumor Necrosis FactorTransforming Growth Factor betaBiomarkersC-Reactive ProteinGrowth Differentiation Factor 15HydrocortisoneInterferon-gammaInterleukin-10Interleukin-17Interleukin-1betaInterleukin-23Interleukin-6Receptors, Tumor Necrosis FactorTransforming Growth Factor betaTransforming Growth FactorsTumor Necrosis Factor-alphacortisolcytokineshypothalamic-pituitary-adrenal axisimmune-inflammatory biomarkersnon-specific low back pain

Identifiers

PMID36119028
PMCPMC9478440
OpenAlexW4294203849

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.